Differential Morbidity in Preterm Small versus Appropriate for Gestational Age: Perhaps Unverifiable

Caroline C. Marrs; Hector Mendez-Figueroa; Ibrahim A. Hammad; Suneet P. Chauhan

doi:10.1055/s-0035-1552939

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2015; 32(13): 1251-1256
DOI: 10.1055/s-0035-1552939

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Differential Morbidity in Preterm Small versus Appropriate for Gestational Age: Perhaps Unverifiable

Caroline C. Marrs

¹Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, UT Health Science Center at Houston, Houston, Texas

,

Hector Mendez-Figueroa

¹Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, UT Health Science Center at Houston, Houston, Texas

,

Ibrahim A. Hammad

²Department of Obstetrics-Gynecology, Eastern Virginia Medical School, Norfolk, Virginia

,

Suneet P. Chauhan

¹Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, UT Health Science Center at Houston, Houston, Texas

› Institutsangaben

Abstract

Objective The objective of this study was to determine the morbidity of preterm small for gestational age (SGA) infants compared with appropriate for GA (AGA).

Study Design This is a secondary analysis of the randomized trial evaluating magnesium sulfate for the prevention of cerebral palsy (CP). We compared outcomes of preterm (< 37 weeks) nonanomalous infants who were SGA (birth weight < 10% for GA) versus AGA (birth weight 10–89% for GA). We compared (1) the parent trial primary outcome, a composite of stillbirth, infant death by 1 year of age, or moderate to severe CP at 2 years of age and (2) composite neonatal morbidity (CNM).

Results Of the 1,948 infants who met inclusion criteria, 95% were AGA and 5% were SGA. The primary outcome was similar (10 and 15%, p = 0.08), as was the CNM (24 and 25%, p = 0.89). Sample size calculations indicate that detection of a one-third higher rate of CNM among SGA compared with AGA infants requires more than 93,900 preterm births; for a one-third difference in moderate to severe CP, more than 1.4 million infants.

Conclusion Owing to the prohibitive sample size required, ascertaining a difference in sequela between preterm SGA and AGA infants is possibly unverifiable.

Keywords

preterm birth - small for gestational age - neonatal morbidity - cerebral palsy

Volltext

Referenzen

References
1 American College of Obstetrics and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol 2013; 121 (5) 1122-1133
2 Royal College of Obstetricians and Gynaecologists. The Investigation and Management of Small-for-Gestational-Age Fetus. Green–Top Guideline no. 31. London: RCOG; 2013
3 Lausman A, Kingdom J, Gagnon R , et al; Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can 2013; 35 (8) 741-757
4 McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340 (16) 1234-1238
5 Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 2004; 191 (2) 481-487
6 Chen HY, Chauhan SP, Ward TC, Mori N, Gass ET, Cisler RA. Aberrant fetal growth and early, late, and postneonatal mortality: an analysis of Milwaukee births, 1996-2007. Am J Obstet Gynecol 2011; 204 (3) 261.e1-261.e10
7 O'Callaghan ME, MacLennan AH, Gibson CS , et al; Australian Collaborative Cerebral Palsy Research Group. Epidemiologic associations with cerebral palsy. Obstet Gynecol 2011; 118 (3) 576-582
8 Arends NJ, Boonstra VH, Hokken-Koelega AC. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age. Pediatrics 2004; 114 (3) 683-690
9 Berghella V. Prevention of recurrent fetal growth restriction. Obstet Gynecol 2007; 110 (4) 904-912
10 Rasmussen S, Irgens LM, Skjaerven R, Melve KK. Prior adverse pregnancy outcome and the risk of stillbirth. Obstet Gynecol 2009; 114 (6) 1259-1270
11 Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982; 59 (5) 624-632
12 Rouse DJ, Hirtz DG, Thom E , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (9) 895-905
13 Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3: 6
14 Manuck TA, Varner MW. Neonatal and early childhood outcomes following early vs later preterm premature rupture of membranes. Am J Obstet Gynecol 2014; 211 (3) 308.e1-308.e6
15 Wilcox AJ, Weinberg CR, Basso O. On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol 2011; 174 (9) 1062-1068
16 Ananth CV, VanderWeele TJ. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol 2011; 174 (1) 99-108
17 Basso O, Wilcox AJ. Might rare factors account for most of the mortality of preterm babies?. Epidemiology 2011; 22 (3) 320-327
18 VanderWeele TJ, Mumford SL, Schisterman EF. Conditioning on intermediates in perinatal epidemiology. Epidemiology 2012; 23 (1) 1-9
19 von Elm E, Altman DG, Egger M , et al; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Int J Surg 2014; 12 (12) 1495-1499
20 Grobman WA, Lai Y, Rouse DJ , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. The association of cerebral palsy and death with small-for-gestational-age birthweight in preterm neonates by individualized and population-based percentiles. Am J Obstet Gynecol 2013; 209 (4) 340.e1-340.e5
21 Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992; 339 (8788) 283-287
22 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87 (2) 163-168